Endothelial and smooth muscle cell transformation in atherosclerosis
- PMID: 26218417
- DOI: 10.1097/MOL.0000000000000219
Endothelial and smooth muscle cell transformation in atherosclerosis
Abstract
Purpose of review: Physiologically, endothelial integrity and smooth muscle homeostasis play key roles in the maintenance of vascular structure and functions. Under pathological conditions, endothelial and smooth muscle cells display great plasticity by transdifferentiating into other cell phenotypes. This review aims to update the progress in endothelial and smooth muscle cell transformation and to discuss their underlying mechanisms.
Recent findings: At the early stage of atherosclerosis, it was traditionally believed that smooth muscle cells from the media migrate into the intima in which they proliferate to form neointimal lesions. Recently, endothelial cells were shown to undergo transformation to form smooth muscle-like cells that contribute to neointimal formation. Furthermore, not only can medial smooth muscle cells migrate and proliferate, they also have the ability to differentiate into macrophages in the intima in which they form foam cells by uptaking lipids. Finally, the discovery of stem/progenitor cells in the vessel wall that can differentiate into all types of vascular cells has complicated the research field even further.
Summary: Based on the current progress in the research field, it is worthy to explore the contributions of cell transformation to the pathogenesis of atherosclerosis to understand the mechanisms on how they are regulated in order to develop novel therapeutic application targeting these processes to reverse the disease progression.
Similar articles
-
Recent insights into the cellular biology of atherosclerosis.J Cell Biol. 2015 Apr 13;209(1):13-22. doi: 10.1083/jcb.201412052. J Cell Biol. 2015. PMID: 25869663 Free PMC article. Review.
-
Vascular progenitor cells and translational research: the role of endothelial and smooth muscle progenitor cells in endogenous arterial remodelling in the adult.Clin Sci (Lond). 2009 Feb;116(4):283-99. doi: 10.1042/CS20080001. Clin Sci (Lond). 2009. PMID: 19138170 Review.
-
The impact of progenitor cells in atherosclerosis.Nat Clin Pract Cardiovasc Med. 2006 Feb;3(2):94-101. doi: 10.1038/ncpcardio0396. Nat Clin Pract Cardiovasc Med. 2006. PMID: 16446778 Review.
-
An update on the phenotypic switching of vascular smooth muscle cells in the pathogenesis of atherosclerosis.Cell Mol Life Sci. 2021 Dec 22;79(1):6. doi: 10.1007/s00018-021-04079-z. Cell Mol Life Sci. 2021. PMID: 34936041 Review.
-
The roles of mechanotransduction, vascular wall cells, and blood cells in atheroma induction.Vascular. 2019 Feb;27(1):98-109. doi: 10.1177/1708538118796063. Epub 2018 Aug 29. Vascular. 2019. PMID: 30157718 Review.
Cited by
-
MiR-130a-3p inhibits endothelial inflammation by regulating the expression of MAPK8 in endothelial cells.Heliyon. 2024 Jan 17;10(2):e24541. doi: 10.1016/j.heliyon.2024.e24541. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38298633 Free PMC article.
-
The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications.Cells. 2023 Sep 19;12(18):2312. doi: 10.3390/cells12182312. Cells. 2023. PMID: 37759535 Free PMC article. Review.
-
IRE1α: from the function to the potential therapeutic target in atherosclerosis.Mol Cell Biochem. 2023 Jun 13. doi: 10.1007/s11010-023-04780-6. Online ahead of print. Mol Cell Biochem. 2023. PMID: 37310588 Review.
-
Sphingolipids in Atherosclerosis: Chimeras in Structure and Function.Int J Mol Sci. 2022 Oct 8;23(19):11948. doi: 10.3390/ijms231911948. Int J Mol Sci. 2022. PMID: 36233252 Free PMC article. Review.
-
Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics.Signal Transduct Target Ther. 2022 Aug 2;7(1):265. doi: 10.1038/s41392-022-01125-5. Signal Transduct Target Ther. 2022. PMID: 35918332 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
